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Aims The time course of atherosclerosis burden in distinct vascular territories remains poorly understood. We longitud-
inally evaluated the natural history of atherosclerotic progression in two different arterial territories using high spatial
resolution magnetic resonance imaging (HR-MRI), a powerful, safe, and non-invasive tool.
Methods
and results
We prospectively studied a cohort of 30 patients (mean age 68.3, n ¼ 9 females) with high Framingham general car-
diovascular disease 10-year risk score (29.5%) and standard medical therapy with mild-to-moderate atherosclerosis
intra-individually at the level of both carotid and femoral arteries. A total of 178 HR-MRI studies of carotid and
femoral arteries performed at baseline and at 1- and 2-year follow-up were evaluated in consensus reading by
two experienced readers for lumen area (LA), total vessel area (TVA), vessel wall area (VWA ¼ TVA2 LA), and
normalized wall area index (NWI ¼ VWA/TVA). At the carotid level, LA decreased (23.19%/year, P ¼ 0.018),
VWA increased (+3.83%/year, P ¼ 0.019), and TVA remained unchanged. At the femoral level, LA remained
unchanged, VWA and TVA increased (+5.23%/year and +3.11%/year, both P, 0.01), and NWI increased for
both carotid and femoral arteries (+2.28%/year, P ¼ 0.01, and +1.8%/year, P ¼ 0.033).
Conclusion The atherosclerotic burden increased significantly in both carotid and femoral arteries. However, carotid plaque pro-
gression was associated with negative remodelling, whereas the increase in femoral plaque burden was compensated
by positive remodelling. This finding could be related to anatomic and flow differences and/or to the distinct degree
of obstruction in the two arterial territories.
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Introduction
Recently, there has been an increasing interest in studies of non-
coronary atherosclerosis. Determinants of this renewed interest
are the perception that atherosclerosis represents a systemic
disease with manifestations in multiple vascular beds and that the
presence of peripheral vascular disease is one of the most formid-
able prognostic predictors of cardiovascular morbidity and
mortality.1
Progression of atherosclerosis has been studied extensively
post-mortem and in vivo in coronary arteries using invasive
methods (e.g. angiography, intra-vascular ultrasound, and emerging
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non-invasive techniques). Although angiography remains the main-
stay procedure for evaluation of flow-limiting stenosis in both cor-
onary and peripheral artery diseases, in the clinical research field,
there is increasing interest in non-invasive imaging techniques
that assess not only the vascular lumen (‘luminogram’) but also
the vessel wall and the plaque.2
High spatial resolution magnetic resonance imaging (HR-MRI)
has been used to study human atherosclerotic lesions in several
vascular beds, and its accuracy and reproducibility in measuring
atherosclerotic plaques has been reported.3–6 Ex vivo and in vivo
studies in animals and in humans have clearly demonstrated the
high potential of MRI in evaluating atherosclerotic plaques in differ-
ent vascular territories non-invasively.7,8 In addition, MRI can safely
assess the effects of drugs and/or mechanical treatments, such as
the action of statins or balloon angioplasty.9,10 Few studies have
simultaneously compared the natural course of atherosclerosis of
two different vascular beds (carotid and aorta or carotid and cor-
onary arteries),11 and to our knowledge, no previous prospective
study using HR-MRI plaque imaging at the level of both carotid and
femoral arteries has been conducted to quantify the evolution of
atherosclerosis.11,12
In this prospective study, we aimed to evaluate both carotid and
femoral levels intra-individually in patients with a high Framingham
cardiovascular risk score using HR-MRI.
Methods
Study population
Patients were recruited from our outpatient vascular clinic, where they
were evaluated for carotid and femoral artery diseases. Screening was
performed using duplex ultrasound of the extracranial cerebral
arteries. Patients were considered eligible for inclusion in the protocol
if they presented with an asymptomatic ,70% carotid artery stenosis.
Patients were not eligible for the study if they had non-atherosclerotic
occlusive disease, severe claustrophobic reactions or short-term life-
threatening pathology (life expectancy ,12 months), or were preg-
nant. Only patients who underwent the complete protocol with
plaque HR-MRI of both carotid and femoral arteries at each time
point (baseline, 1-, and 2-year follow-up) were considered for statisti-
cal analysis. The study complies with the Declaration of Helsinki, the
local ethics committee approved the protocol, and the patients gave
their informed consent.
Baseline examination included: medical history, cardiovascular
examination, and laboratory analysis (haemoglobin, haematocrit, total
white blood cells, platelets, creatinine, HbA1c-glycosylated haemo-
globin, cholesterol profile, hs-CRP, homocysteine, and microalbumi-
nuria) as well as blood sampling for potential evaluation of additional
future markers and duplex ultrasound of the epiaortic arteries. All
the patients were treated with standard medical care.
High-resolution magnetic resonance imaging
The MRI protocol included the completion of HR-MRI of both the
carotid and femoral arteries at baseline and at 1- and 2-year follow-up,
totalling six scans per patient. As specified by the study protocol, only
patients who completed the entire 2-year follow-up, including the full
HR-MRI examination of both carotid and femoral arteries, were con-
sidered for final evaluation. High spatial resolution magnetic resonance
imaging scanning of the carotid and femoral arteries was performed as
a separate investigation within a time frame of ,2 weeks. A 1.5 T unit
(Gyroscan Intera, release 11; Philips Medical Systems, Best, The
Netherlands) with a gradient strength of 30 mT/m and a slew rate of
150 mT/m/ms was used.
For imaging of the carotid arteries, a bilateral, four channel,
phased-array (receive only) coil (Machnet BV, TD Elde, The
Netherlands) was carefully positioned at the level of the carotid bifur-
cation and used for all data collection. The protocol started with scout
images and a two-dimensional (2D) time-of-flight (TOF)
MR-angiography sequence to localize the carotid bifurcations. This
was followed by a sagittal T1-weighted (T1w), double inversion recov-
ery, fast spin echo (2IR-FSE) sequence at the level of the index
common carotid artery bifurcation to allow precise localization of
the bifurcation, plaque extension, and therefore reproducible planning
of the subsequent MR images (Figure 1). The 2IR-FSE sequence allows
nulling of the signal from the flowing blood and is known as blackblood
MRI. Axial, 2D, ECG-triggered, 2IR-FSE sequences centred at the index
carotid artery bifurcation using T1w, proton density-weighted (PDw),
and T2-weighted (T2w) imaging sequences with spectral fat saturation
were performed using the following parameters: slice thickness, 2 mm;
number of slices, 12; acquired in-plane resolution, 0.63 × 0.63 mm
(reconstructed 0.31 × 0.31 mm); NSA, 2; repetition time (TR), 1 RR
interval for T1w and 3 RR for PDw and T2w; echo time (TE), 7, 12,
and 50 ms for T1w, PDw, and T2w images, respectively. In addition,
an axial 3D TOF sequence was acquired in the same position as the
2IR-TSE sequences with the following imaging parameters: number
of slices, 12; slice thickness, 2 mm; acquired in-plane resolution,
0.63 × 0.63 mm (reconstructed 0.31 × 0.31 mm); NSA, 2; TR, 23;
TE, 2.1; flip angle, 258.
Femoral artery MRI studies were performed in separate imaging ses-
sions using a previously described imaging protocol.10 The MRI proto-
col consisted of three steps: (i) gradient echo (scout) series to localize
anatomic structures; (ii) TOF MRI angiography to localize the stenotic
lesion of interest and to define the precise location of the index steno-
sis by measuring the distance from femoral artery bifurcation to the
lesion of interest, therefore allowing reproducible positioning of
(iii) plaque imaging sequences in all follow-up studies (Figure 1). Three-
dimensional T2w, PDw, T1w, ECG-triggered, 2IR-FSE sequences were
used to acquire cross-sectional images of the vessel wall with the fol-
lowing parameters: slice thickness, 2.5 mm; number of slices, 10;
acquired in-plane resolution, 0.35 × 0.42 mm (reconstructed 0.18 ×
0.18 mm); NSA, 2; TR, 1 RR interval for T1w and 2–3 RR for PDw
and T2w, respectively; TE, 9.4 ms for T1w and PDw and 40 ms for
T2w images; echo train length was 6 for T1w and 24 for PDw and
T2w images. Spectral suppression was used for black blood images
(T1w, PDw, and T2w) to reduce signal from subcutaneous fat.
Spatial presaturation slabs were used to eliminate aliasing resulting
from the small field of view (90 × 90 mm). In order to obtain opti-
mized signal-to-noise ratio, a small circular superficial receive-only
coil (diameter 8 cm), centred at the region of interest, was used for
all 2IR-FSE sequences. The index femoral lesions were located from
the level of femoral bifurcation to the distal femoral artery. If no
clear atherosclerotic lesion was detected on the TOF MRI angiography
during the baseline study, high-resolution plaque imaging sequences
were centred at the level of the common femoral artery bifurcation.
The approximate duration of the MR study was 40–50 min for the
carotid artery and 35–45 min for the femoral artery.
Duplex ultrasound imaging
A single experienced ultrasonographer performed all Duplex examin-
ations with a 7 MHz linear-array transducer on a Sequoia 512 unit
(Acuson Inc., Mountain View, CA, USA) at our outpatient vascular
unit during the screening phase, at baseline, and at 1- and 2-year
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follow-up. The examination was performed with the patient in the
supine position with the head resting on a support pillow for at least
15 min. Sites of examination included the key lesion, the common
carotid artery, and the internal carotid artery. The study was started
low in the neck by visualizing the common carotid artery along its
longitudinal axis. The transducer was then moved towards the base
of the skull to identify the carotid bulb and the internal and external
carotid arteries. For carotid artery stenosis, estimation of obstruction
was completed using B-mode evaluation in short and long axes as well
as previously described semi-quantitative Doppler assessment.13–15
Image analysis
Magnetic resonance imaging studies were transferred from a PACS/RIS
system (Philips Medical Systems) to a dedicated software program
(GTVolume v.1.3 for Windows, GyroTools Ltd, Switzerland) used to
analyse the morphometrics of the cross-sectional MR images with
the aid of a touch screen device (pen display DTU-1931, Wacom
Co. Ltd). Two trained reviewers (a radiologist with 8 years of experi-
ence in magnetic resonance plaque imaging and one research fellow
with 1 year of experience) evaluated the images in consensus.
To further maximize co-registration among follow-up studies, meti-
culous alignment of the images was performed before final evaluation
according to the level of the carotid bifurcation or of identical external
anatomical landmarks (e.g. small veins on images of the femoral artery)
as shown in Figure 2. At the carotid level, all matched images from the
common to internal carotid artery present in each follow-up examin-
ation were used for further analysis.
Luminal area (LA) was defined as the area encompassed by the inner
boundary of the intimal surface. Total vessel area (TVA) was defined by
the outer boundary of the vessel. Vessel wall area (VWA) was calcu-
lated by the software subtracting TVA from LA (VWA ¼ TVA 2
LA). These parameters are outlined in Figure 3. Luminal area and
TVA were assessed on T1w images; if image quality was not sufficient,
T2w or PDw images were used instead.16 Images with poor quality
were excluded from evaluation. A normalized wall index was then cal-
culated (NWI ¼ VWA/TVA). Inter-reader and intra-reader reproduci-
bility were evaluated for 10 randomly selected patients at both carotid
artery and femoral artery levels for a total of 20 segments. Intra-class
correlation coefficient (ICC) for the agreement between two oper-
ators/two repeated measures were calculated with 95% confidence
interval for the TVA, LA, and VWA.
Figure 2 Matching of magnetic resonance images at the level of the carotid artery over time. Matching of the axial magnetic resonance images
from baseline to 2-year follow-up on the basis of reference anatomic landmarks, e.g. carotid bifurcation (arrowhead) allowed correct alignment
of the slices.
Figure 1 Magnetic resonance imaging method for serial plaque imaging. Left: sagittal high spatial resolution magnetic resonance imaging image
at the level of the carotid bifurcation shows an extensive atherosclerotic plaque with positive remodelling of the internal and common carotid
artery (T1-weighted, double inversion recovery). The yellow box indicates the positioning of subsequent axial high spatial resolution magnetic
resonance imaging sequences. Right: magnetic resonance imaging method for serial plaque imaging at the femoral level. After localization of the
stenosis of interest, a three-dimensional volume (yellow box), containing 10 contiguous cross-sectional images perpendicular to the lumen axis
was acquired and carefully matched over time using measurements from anatomical landmarks (such as common femoral artery bifurcation).
Manual tracing of vessel border (lumen in red and outer border in blue) was performed to quantify vessel dimensions (lower panel). Outer
vessel border defined the total vessel area. V, Femoral vein.
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Data management and statistical analysis
Summary statistics are shown as the mean of the values+ SD. The
means of morphometric variables are intended as a sum of all areas
divided by the number of slices summarized across all subjects. Two
intermediate missing values were replaced by the mean of extremes.
Only data from location-matched images were considered for analysis.
Changes are presented as mean evolution between visits and as
annualized rates both for absolute and per cent values. Evolutions
between visits were analysed using analysis of variance for repeated
measures and the comparison of annual change to zero using one
sample t-test. Values were tested for normal distribution. Statistical sig-
nificance was defined as a value of P,0.05, two-tailed. All graphs and
calculations were performed using SPSS 18.0 and GraphPad Prism 5.0.
Data management was performed with Filemaker Pro v10.0v3.
Results
Forty-five patients screened by Duplex ultrasound between June
2006 and March 2008 were considered for MRI plaque imaging.
Thirty patients underwent the complete MRI protocol of both
carotid and femoral plaque at baseline and at 1- and 2-year
follow-up. In total, this led to 178 MRI studies (one patient
missed at the 1-year carotid and femoral follow-up visit). Five
patients chose not to continue with the follow-up studies (two
of them presented with claustrophobia), four patients had to be
excluded because of limited image quality, three patients died,
two patients underwent stenting because of plaque progression
(one at the carotid and one at the femoral levels), and one
patient could not complete the follow-up due to pacemaker
placement.
Clinical data
The majority of patients were more than 55 years old and pre-
sented mild-to-moderate increase in arterial blood pressure,
despite pharmacological treatment. Half presented with a history
of coronary artery disease (CAD), more than 65% were
smokers or ex-smokers, and one-third of patients suffered from
diabetes mellitus. Hyperlipidaemia was present in .90% of the
patients, and despite antilipidaemic drugs, the mean cholesterol
LDL level at baseline was 2.9 mmol/L (+0.96) and 2.44 mmol/L
(+0.87) at the second year (P ¼ 0.03). Sixty-eight per cent of
the patients were on statin therapy for more than 2 years.
Other baseline characteristics, medication, and laboratory results
of the population were stable during follow-up and are shown in
Table 1.
High spatial resolution magnetic
resonance imaging
A total of 1068 HR-MRI cross-sectional images of the carotid
arteries (360 at BL, 348 at 1 year, and 360 at 2 years) and 890
cross-sections at the level of the femoral arteries (300 at BL,
290 at 1 year, and 300 at 2 years) were evaluated. Mean follow-up
time was 2.18 (+0.19) years at the carotid level and 2.16 (+0.18)
years at the femoral level. Mean interval time between carotid and
femoral HR-MRI was 9.3 days (+31.7). Progression during the
2-year follow-up is shown in Figure 4. At the carotid level, LA
decreased (23.19%/year, P ¼ 0.018) while VWA increased
(+3.83%/year, P ¼ 0.019) and TVA remained unchanged. At the
femoral level, LA remained unchanged, while VWA and TVA
increased (+5.23%/year and +3.11%/year, both P, 0.05). Nor-
malized wall index increased for both the carotid (+2.28%/year,
P ¼ 0.01) and femoral (+1.8/year, P ¼ 0.033) arteries. The
detailed data of LA, VWA, and TVA as assessed by HR-MRI are
provided in Table 2. Figure 5 shows an example of HR-MRI cross-
sections in the same patient at the level of the carotid and femoral
arteries at baseline and during follow-up. The distinct remodelling
process is emphasized in the schematic representation (Figure 6).
Inter-observer ICCs of TVA, LA, and VWA were, respectively,
0.99 [95% confidence interval (CI): 0.96–0.99], 0.97 (0.93–0.98),
and 0.97 (95% CI: 0.91–0.98) and intra-observer ICCs were 0.98
(95% CI: 0.96–0.99), 0.97 (95% CI: 0.94–0.99), and 0.96 (95%
CI: 0.90–0.98).
Duplex
Duplex ultrasound of the index carotid arteries (Table 2) revealed
progression of the degree of stenosis at the carotid level of +3.3%/
year (+5.3%). The degree of arterial obstruction at baseline in the
two vascular territories was different: at the carotid arteries, 53%
of patients had a stenosis of .50%, whereas at the femoral level,
only 22% of the patients had a stenosis of .50%.
Clinical follow-up and morphometric
values
The Framingham general cardiovascular disease 10-year risk score
at baseline was 29.5%. In the 45 patients who were initially
included, we observed three deaths, seven cerebrovascular
events, and seven acute coronary syndromes. There was no
Figure 3 Carotid artery tracing. Atheromatous plaque of the
internal carotid artery: lumen area (LA, red line) and total
vessel area (TVA, blue line) are manually outlined. Vessel wall
area (VWA ¼ TVA2 LA) is calculated by the software. Also
note the external carotid artery (ECA) and the right jugular
vein (JV).
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Figure 4 Line graphs of atherosclerotic progression. Evolution of mean lumen area (LA), vessel wall area (VWA), and total vessel area (TVA)
at the carotid (left) and femoral (right) levels; plots with error bars (95% confidence interval).
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Table 1 Clinical data of the analysed population (n 5 30): demographics, medications, medical history, and laboratory
results
Demographics and medications Mean + SD or % Medical history and laboratory Mean + SD or %
Age (years) 68.3 + 8.1 History of CAD (%) 46.7
Female sex (%) 30.0 Family history of CAD (%) 30.0
Height (cm) 167.1 + 7.8 Smokers (%) 26.7
Weight (kg) 74.9 + 10.7 Ex-smokers (%) 40.0
Body mass index (kg/m2) 26.7 + 2.6 Smoke-free (years) 11.3 + 11.2
Pulse (b.p.m) 64.4 + 11.9 Hypertension (%) 86.7
BP systolic (mmHg) 143.4 + 20.5 History of heart failure (%) 3.3
BP diastolic (mmHg) 78.1 + 8.4 Diabetes mellitus (%) 30.0
Claudicatio (%) 33.3
Anticoagulation (%) 3.3 Hyperlipidaemia (%) 96.7
Aspirin (%) 80.0 COPD (%) 3.3
Clopidogrel or others (%) 56.7 Other medical relevant conditions (%) 63.3
ACE inhibitor (%) 33.3 Framingham 10 years CVD score (%) 29.5
Angiotensin receptor blocker (%) 30.0
b-Blocker (%) 60.0
Calcium antagonist (%) 36.7 Creatinine (mmol/L) 111.3 + 50.0
Nitrates (%) 3.3 Cockcroft–Gault clearance (mL/min) 63.6 + 22.4
Oral antidiabetics (%) BL 26.7 Microalbuminuria (mg/L)* 23.9 (17.5–202.0)
Insulin (%) 13.3 Cholesterol (mmol/L) 4.8 + 1.2
Hypolipdaemic, statin (%) 86.7 LDL (mmol/L) 2.9 + 0.9
Time since beginning (years) 3.8 + 3.53 HDL (mmol/L) 1.4 + 0.4
Atorvastatin (%) 56.7 Triglycerides (mmol/L)* 1.6 (1.2–2.5)
Simvastatin (%) 13.3 A1c haemoglobin (DCCT) 6.3 + 1.5
Pravastatine (%) 10.0 Haemoglobin (g/dL) 14.2 + 1.6
Fluvastatin (%) 6.7 hs-PCR (mg/L)* 1.9 (1.0–2.3)
Hypolipdaemic, other than statin (%) 20.0 Homocysteine (mmol/L) 17.1 + 7.3
*Median, first, and third inter-quartile value for data with non-normal distribution.
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statistically significant correlation between the morphometric MRI
parameters and the occurrence of clinical cardiovascular events.
Discussion
Our in vivo prospective study on the natural history of athero-
sclerosis progression using serial high-resolution magnetic reson-
ance imaging indicates that the atherosclerotic burden increases
in both the carotid and femoral arteries. However, atherosclerosis
presents a distinct intra-individual pattern of progression in the
two arterial territories, with a negative remodelling at the level
of the obstructed carotid artery and a positive remodelling at
the level of the femoral arteries. To our knowledge, this is the
first prospective study that systematically assessed progression of
atherosclerotic burden intra-individually by HR-MRI at both the
carotid and peripheral levels on a yearly basis. The results
showed an increase in the mean VWA (+3.83%/year) at the
level of the carotid arteries and a reduction in lumen area
(23.19%/year), despite standard medical care (Table 1), whereas
at the femoral level, the increase in VWA (+5.23%/year) was
not accompanied by a decrease in the lumen area
(Figures 4, 5 and 6). This distinct pattern of vascular remodelling
in two different vascular beds within the same patient could have
several explanations. The observed differences between the two
territories in our study may be related to anatomic and flow differ-
ences, such as vessel dimensions, tortuosity, bifurcation, and
diverse flow conditions (high and low resistance flows at the
femoral and carotid levels, different streamlines, and shear
stress). Conversely, the different remodelling behaviours in our
patients in the two territories cannot be related to differences in
medical therapy, risk factors, or genetic profile because biological
differences were excluded by our study design, with intra-individual
comparison of two different vascular territories by HR-MRI.
Another plausible explanation for the different remodelling pat-
terns is the distinct degree of obstruction at the two vascular
locations. This explanation is in accordance with the Glagov para-
digm.17 Our patients presented a more advanced degree of
obstruction at the level of the carotid arteries, and consistent
with Glagov, the VWA increased while the LA decreased. Conver-
sely, at the level of the femoral arteries, with a lesser degree of
Figure 5 Example magnetic resonance images of both territories. Top: axial magnetic resonance images (T1-weighted, double inversion
recovery) at the level of the internal carotid artery at BL; 1- and 2-year follow-up shows a negative remodelling with moderate luminal narrow-
ing. Bottom: axial oblique plane high spatial resolution magnetic resonance imaging images of the common femoral artery
(three-dimensional-T1-weighted-double inversion recovery) of the same patient showing eccentric atherosclerotic remodelling at baseline
and at 1- and 2-year follow-up.
Figure 6 Schematic representation of remodelling. Remodel-
ling at the level of the carotid and femoral arteries has been
emphasized in order to show the evolution.
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obstruction of the vessel wall, the progression of the atherosclero-
tic plaque continued to underlie a positive remodelling with a sig-
nificant increase in the VWA albeit without a concomitant increase
in the obstruction.
Hayashi et al.11 have recently reported retrospective data of
patients who eventually underwent HR-MRI at the level of the
thoracic-abdominal aorta and carotid arteries, indicating a possible
distinct progression pattern in the various territories. In contrast,
our prospective data definitely point to the differential behaviour
of atherosclerosis according to its localization and stage.
At the level of the carotid arteries, our results are in agreement
with the recent data of Saam et al.18 Surprisingly, we found a positive
remodelling with augmentation of VWA and preservation of the LA
at the level of the femoral arteries. This is in contrast with the post-
mortemfindings of Pasterkamp et al.19 and of Li et al.20 usingHR-MRI,
who both found that the constrictive remodelling pattern was more
prevalent at the level of the peripheral arteries than at the level of the
coronary and carotid arteries. This can partially be explained by the
high degree of femoropopliteal obstruction among their patients
when compared with our cohort, in which only 22% of patients
had a femoral obstruction .50%.
Carotid and peripheral arteries—like the coronary arteries—
may undergo circumferential changes in response to atherosclero-
tic lesion formation.17,19 Arterial remodelling remains a major
determinant of luminal narrowing in all vascular beds; a determinis-
tic mechanism for maintaining patency of the lumen in the pres-
ence of atherosclerosis. Conversely, there is evidence that
arteries undergoing an important positive remodelling harbour a
high risk of complications and are more prone to plaque compli-
cations, such as plaque rupture with exposure of the lipid-rich
core or plaque haemorrhage. Although our project was not
focused on acute ischaemic cerebral complications, this underlines
the relevance of plaque composition and the potential of HR-MRI
in detecting plaque complication as recently emphasized.21
The prevalence and clinical presentation of expansively remo-
delled lesions may differ depending on location within the arterial
tree, as indicated not only by our results but also according to the
location along the vessel. High spatial resolution magnetic reson-
ance imaging constitutes an ideal tool to study acute and chronic
remodelling at the level of the carotid and lower limb arteries
in vivo and non-invasively. Using the same technique, we recently
reported on acute and long-term ‘in vivo’ vascular effects in patients
undergoing endovascular therapy of the lower limb arteries.10,22
Study limitations
The relatively small cohort of patients in this study does not allow
extrapolation of our results to a larger cohort and this is the main
limitation of the study. We are aware that the observations in our
study refer to mean values of the HR-MRI-derived parameters
obtained from selected arterial segments. Therefore, the results
may neither reflect systemic remodelling nor regional effects in
the same vessel segment.
There was a trend to progression of TVA at the level of the
carotid artery, although not significant (P ¼ 0.089), the power of
the test being only 55%. In order to show a significant increase
with a power of 80%, 60 patients would have been necessary, a
number of patients far beyond the possibilities of the present
very demanding protocol.
Our study design with recruitment of patients based primarily
on asymptomatic ,70% carotid stenosis led to the fact that the
degree of stenosis was more advanced in the carotid than in the
femoral arteries which may contribute to the distinct progression
of atherosclerosis between these vascular territories.
The LDL cholesterol levels at entry were higher than those rec-
ommended for secondary prevention in CAD and approximately
two-thirds of patients were on statins for more than 2 years at
the time they were included in the study: these two factors
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Table 2 High spatial resolution magnetic resonance imaging (morphologic values) and duplex results (stenotic degree)
at the carotid level and (morphologic values) at the femoral level
Baseline + 1
SD
First visit + 1
SD
Second visit + 1
SD
P-value D/year abs + 1
SD
D/year % + 1
SD
P-value
Means (data based on matched locations) ANOVA t-test
Carotid artery (n ¼ 30)
Lumen area (mm2) 25.61 + 8.59 24.97 + 8.42 23.78 + 8.74 0.018 20.85 + 1.83 23.19 + 7.21 0.017
Vessel wall area (mm2) 46.69 + 9.75 48.62 + 10.55 50.39 + 12.12 0.019 1.69 + 3.55 3.83 + 8.39 0.014
Total vessel area (mm2) 72.29 + 15.65 73.59 + 16.69 74.17 + 16.28 0.156 0.88 + 2.73 1.35 + 4.24 0.089
Normalized wall index 0.65 + 0.06 0.66 + 0.06 0.68 + 0.08 0.010 0.01 + 0.03 2.28 + 4.49 0.01
Stenotic degree at
duplex (%)
49.0 + 12.1 51.5 + 12.9 55.7 + 14.8 <0.001 0.04 + 0.05 0.001
Femoral artery (n ¼ 30)
Lumen area (mm2) 20.91 + 9.81 21.25 + 10.16 21.06 + 10.14 0.860 0.03 + 1.69 0.01 + 8.31 0.926
Vessel wall area (mm2) 33.23 + 11.44 34.15 + 12.91 37.11 + 14.72 0.007 1.80 + 3.29 5.23 + 9.53 0.005
Total vessel area (mm2) 54.15 + 20.37 55.40 + 22.04 58.17 + 23.56 0.024 1.83 + 3.80 3.11 + 7.32 0.013
Normalized wall index 0.62 + 0.07 0.63 + 0.07 0.64 + 0.07 0.033 0.01 + 0.02 1.80 + 3.68 0.021
P-values from one-way ANOVA (repeated measures) for the mean values and t-test of the annualized (D/year) absolute values.
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could explain the lack of regression of atherosclerosis as found in
previous studies.23,24
The relatively high number of patients (15 of 45) that dropped-
out of the study represents another limitation; however, this
appears to be in accordance with previous studies.25
Our study focused on progression of atherosclerosis based on
measurements of lumen and VWA, but we did not assess plaque
components since adequate image quality is mandatory in all
imaging sequences in order to perform reliable analysis of plaque
composition. This would have led to further drop-out of a signifi-
cant number of studies reducing thereby furthermore the number
of patients with a complete set of follow-up studies and therefore
meaningful statistical evaluation would have likely become imposs-
ible. In addition, 3D volume imaging acquisition at the level of the
carotid arteries was not performed because it was not feasible at
that time.
Conclusions
Despite a standard medical care, the atherosclerotic burden
increases significantly and similarly in both carotid and femoral
arteries. However, carotid arteries show a pattern of remodelling
that is distinct from that of femoral arteries. This finding, which
needs to be confirmed in further studies, could be related to ana-
tomic and flow differences between the two arterial territories
and/or to the different degrees of obstruction.
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